4D Molecular Therapeutics Inc.
05/13/2026 | Press release | Distributed by Public on 05/14/2026 04:09
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
|
|||||||
4D Molecular Therapeutics Inc. published this content on May 13, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on May 14, 2026 at 10:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]